N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI
暂无分享,去创建一个
Sophia Vinogradov | Angela Jakary | R. Feiwell | S. Vinogradov | R. Deicken | A. Jakary | Raymond F. Deicken | Robert Feiwell
[1] Dorothee P. Auer,et al. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation , 2001, Schizophrenia Research.
[2] Ravi S. Menon,et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.
[3] R. Coppola,et al. Thalamic and Caudate Volumes in Monozygotic Twins Discordant for Schizophrenia , 2001, The Australian and New Zealand journal of psychiatry.
[4] A W Toga,et al. Brain abnormalities observed in childhood-onset schizophrenia: a review of the structural magnetic resonance imaging literature. , 2000, Mental retardation and developmental disabilities research reviews.
[5] Koichi Mori,et al. Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: A preliminary report , 2002, Psychiatry and clinical neurosciences.
[6] Peter Falkai,et al. Volumes of association thalamic nuclei in schizophrenia: a postmortem study , 2003, Schizophrenia Research.
[7] N Schuff,et al. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. , 2000, The American journal of psychiatry.
[8] B. Pakkenberg,et al. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. , 1990, Archives of general psychiatry.
[9] Peter Stoeter,et al. Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling , 2003, NeuroImage.
[10] D. Rothman,et al. Neuronal and glial metabolite content of the epileptogenic human hippocampus , 2002, Annals of neurology.
[11] J Hennig,et al. Absence of N‐acetylaspartate in the human brain: Impact on neurospectroscopy? , 2001, Annals of neurology.
[12] R Jayasundar. Human brain: biochemical lateralization in normal subjects. , 2002, Neurology India.
[13] R. Ledeen,et al. Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.
[14] J. Newcomer,et al. NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.
[15] P. Barker,et al. N‐Acetyl Aspartate—A Neuronal Marker? , 2001, Annals of neurology.
[16] R S Kahn,et al. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. , 2001, The American journal of psychiatry.
[17] Nancy C. Andreasen,et al. Manual and Automated Measurement of the Whole Thalamus and Mediodorsal Nucleus Using Magnetic Resonance Imaging , 2002, NeuroImage.
[18] Ron Kikinis,et al. Volumetric Evaluation of the Thalamus in Schizophrenic Male Patients Using Magnetic Resonance Imaging , 1998, Biological Psychiatry.
[19] R S Kahn,et al. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. , 1998, The American journal of psychiatry.
[20] Cheuk Y. Tang,et al. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. , 2004, The American journal of psychiatry.
[21] V. Govindaraju,et al. Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.
[22] T Sharma,et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. , 2001, The American journal of psychiatry.
[23] K O Lim,et al. In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.
[24] M W Weiner,et al. Spectroscopic imaging display and analysis. , 1992, Magnetic resonance imaging.
[25] B. Cohen,et al. Activation of midline thalamic nuclei by antipsychotic drugs , 1998, Psychopharmacology.
[26] D R Medoff,et al. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.
[27] K O Lim,et al. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. , 1998, Archives of general psychiatry.
[28] S. Paradiso,et al. Recalling word lists reveals "cognitive dysmetria" in schizophrenia: a positron emission tomography study. , 1999, The American journal of psychiatry.
[29] David Bonekamp,et al. Asymmetry and gender effect in functionally lateralized cortical regions: A proton MRS imaging study , 2004, Journal of magnetic resonance imaging : JMRI.
[30] J. Clark,et al. N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.
[31] J. Coyle,et al. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.
[32] N. Schuff,et al. Method to correlate 1H MRSI and 18FDG‐PET , 2000, Magnetic resonance in medicine.
[33] Peter Bachert,et al. A Fully Automated Method for Tissue Segmentation and CSF-Correction of Proton MRSI Metabolites Corroborates Abnormal Hippocampal NAA in Schizophrenia , 2002, NeuroImage.
[34] H. Tost,et al. Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. , 2002, Archives of general psychiatry.
[35] David S Tuch,et al. Automatic segmentation of thalamic nuclei from diffusion tensor magnetic resonance imaging , 2003, NeuroImage.
[36] R. McCarley,et al. MRI anatomy of schizophrenia , 1999, Biological Psychiatry.
[37] M S Buchsbaum,et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. , 1996, The American journal of psychiatry.
[38] Hirohiko Kimura,et al. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy , 2000, Psychiatry Research: Neuroimaging.
[39] D. Louis Collins,et al. Design and construction of a realistic digital brain phantom , 1998, IEEE Transactions on Medical Imaging.
[40] W. Reddick,et al. More than meets the eye: significant regional heterogeneity in human cortical T1. , 2000, Magnetic resonance imaging.
[41] Ravi S. Menon,et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.
[42] B. Morris,et al. Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol , 2002, Neuropharmacology.
[43] A. Pfefferbaum,et al. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. , 2003, The American journal of psychiatry.
[44] B. Trapp,et al. N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve , 2002, Annals of neurology.
[45] P. Teale,et al. The thalamus and the schizophrenia phenotype: failure to replicate reduced volume , 1999, Biological Psychiatry.
[46] Peter Herscovitch,et al. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults , 2002, Psychiatry Research: Neuroimaging.
[47] L. Siever,et al. Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. , 2001, Archives of general psychiatry.
[48] Paul J. Harrison,et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia , 2003, Schizophrenia Research.
[49] Tetsuya Mori,et al. Gender differences in cerebral glucose metabolism: a PET study , 2002, Journal of the Neurological Sciences.
[50] D. Braus,et al. Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study. , 2001, The American journal of psychiatry.
[51] M S Buchsbaum,et al. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. , 1996, Neuropsychobiology.
[52] B. Pakkenberg,et al. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics , 1992, Schizophrenia Research.
[53] N. Andreasen,et al. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task , 2001, Psychological Medicine.
[54] S. Dollfus,et al. Proton magnetic resonance spectroscopy (1H-MRS) of the thalamus in schizophrenia , 2000, European Psychiatry.
[55] K. Bhakoo,et al. In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes , 2000, Journal of neurochemistry.
[56] J. Coyle,et al. N-Acetylaspartate in neuropsychiatric disorders , 1995, Progress in Neurobiology.
[57] D J Healy,et al. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. , 2000, The American journal of psychiatry.
[58] J. Lauriello,et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure , 2002, Schizophrenia Research.
[59] P M Matthews,et al. N‐acetylaspartate: Usefulness as an indicator of viable neuronal tissue , 2001, Annals of neurology.
[60] John Lauriello,et al. Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia , 2001, Psychiatry Research: Neuroimaging.
[61] Alan C. Evans,et al. MRI Simulation Based Evaluation and Classifications Methods , 1999, IEEE Trans. Medical Imaging.
[62] D. German,et al. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia , 2000, Biological Psychiatry.
[63] Norbert Schuff,et al. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder , 2001, Psychiatry Research: Neuroimaging.
[64] C. Heimberg,et al. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect , 1998, Psychiatry Research: Neuroimaging.
[65] Alessandro Bertolino,et al. Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study , 1998, Biological Psychiatry.
[66] G Tedeschi,et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. , 1996, The American journal of psychiatry.
[67] M. Baslow,et al. Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system An analytical review , 2002, Neurochemistry International.
[68] M Noble,et al. Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.
[69] Tommaso Scarabino,et al. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. , 2003, The American journal of psychiatry.
[70] J. Sweeney,et al. Thalamic volumes in patients with first-episode schizophrenia. , 2001, The American journal of psychiatry.
[71] K. Blennow,et al. Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains , 2000, Journal of Neural Transmission.
[72] William Byne,et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. , 2002, The American journal of psychiatry.
[73] J Star-Lack,et al. High spatial resolution 1H‐MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain , 1999, Magnetic resonance in medicine.
[74] E G Jones,et al. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[75] Arthur W. Toga,et al. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia , 2004, NeuroImage.
[76] J. Callicott,et al. The Relationship between Dorsolateral Prefrontal Neuronal N-Acetylaspartate and Evoked Release of Striatal Dopamine in Schizophrenia , 2000, Neuropsychopharmacology.
[77] Thomas Becker,et al. MRI T2 relaxation times of brain regions in schizophrenic patients and control subjects , 1997, Psychiatry Research: Neuroimaging.
[78] M S Buchsbaum,et al. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. , 1999, The American journal of psychiatry.
[79] Christian Gaser,et al. Supporting evidence for the model of cognitive dysmetria in schizophrenia — a structural magnetic resonance imaging study using deformation-based morphometry , 2000, Schizophrenia Research.
[80] Matcheri S Keshavan,et al. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I , 2000, Biological Psychiatry.
[81] James C. Ehrhardt,et al. Visualization of Subthalamic Nuclei with Cortex Attenuated Inversion Recovery MR Imaging , 2000, NeuroImage.
[82] R. Gur,et al. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. , 1998, The American journal of psychiatry.
[83] Núria Bargalló,et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients , 2003, NeuroImage.
[84] N. Andreasen,et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.
[85] Shi-Jiang Li,et al. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.
[86] Katya Rubia,et al. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function , 2001, Schizophrenia Research.
[87] George Fein,et al. Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images , 2001, Psychiatry Research: Neuroimaging.